ConductScience.org, home

Paper39733379

Impact of cataranthine treatment on miRNA34 and miRNA29 levels in HepG2 cells and their association with the expression levels of Bcl-2 and Nrf2.

Heidari-Kalvani N and 4 others. Mol Biol Rep, 2024. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Impact of cataranthine treatment on miRNA34 and miRNA29 levels in HepG2 cells and their association with the expression levels of Bcl-2 and Nrf2. Papers, record 39733379. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39733379

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Impact of cataranthine treatment on miRNA34 and miRNA29 levels in HepG2 cells and their association with the expression levels of Bcl-2 and Nrf2.
PubMed
Journal
Mol Biol Rep
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.57, provisional
iCite
Revised in PubMed
2026-11-01
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Heidari-Kalvani NNafiseh
2Mehdikhani FFariba
3Mohammadi YYaser
4Barjesteh FFereshteh
5Bahreini EElham

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MicroRNAsMajor topic
NF-E2-Related Factor 2Major topic
Proto-Oncogene Proteins c-bcl-2Major topic
Oxidative StressMajor topic
ApoptosisMajor topic
Gene Expression Regulation, NeoplasticMajor topic
Humans
Hep G2 Cells
Liver Neoplasms
Carcinoma, Hepatocellular
Antioxidants
Cell Survival

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
22280Iran University of Medical SciencesPubMed

Source PubMed

Download CSV of grants

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129969760Nrf2 Pathway in Age-Related Neurological Disorders: Insights into MicroRNAs.Cell Physiol Biochem2018https://conductscience.org/library/papers/29969760PubMed
235323487Enhancement of Vindoline and Catharanthine Accumulation, Antioxidant Enzymes Activities, and Gene Expression Levels in Catharanthus roseus Leaves by Chitooligosaccharides Elicitation.Mar Drugs2022https://conductscience.org/library/papers/35323487PubMed
316982684Role of the cyclic AMP response element in the bcl-2 promoter in the regulation of endogenous Bcl-2 expression and apoptosis in murine B cells.Mol Cell Biol2006https://conductscience.org/library/papers/16982684PubMed
432751080Molecular Mechanisms Underlying Hepatocellular Carcinoma Induction by Aberrant NRF2 Activation-Mediated Transcription Networks: Interaction of NRF2-KEAP1 Controls the Fate of Hepatocarcinogenesis.Int J Mol Sci2020https://conductscience.org/library/papers/32751080PubMed
532481552Oxidative Stress Management in Chronic Liver Diseases and Hepatocellular Carcinoma.Nutrients2020https://conductscience.org/library/papers/32481552PubMed
620809797microRNAs: Master regulators as potential therapeutics in cancer.Annu Rev Pharmacol Toxicol2011https://conductscience.org/library/papers/20809797PubMed
731934125miRNA-34a suppresses colon carcinoma proliferation and induces cell apoptosis by targeting SYT1.Int J Clin Exp Pathol2019https://conductscience.org/library/papers/31934125PubMed
831717324The Role of Nrf2 Activity in Cancer Development and Progression.Cancers (Basel)2019https://conductscience.org/library/papers/31717324PubMed
916169904Antioxidants modulate mitochondrial PKA and increase CREB binding to D-loop DNA of the mitochondrial genome in neurons.Proc Natl Acad Sci U S A2005https://conductscience.org/library/papers/16169904PubMed
1020303927cAMP-dependent protein kinase regulates post-translational processing and expression of complex I subunits in mammalian cells.Biochim Biophys Acta2010https://conductscience.org/library/papers/20303927PubMed
1138909847Permeabilization of the outer mitochondrial membrane: Mechanisms and consequences.Biochim Biophys Acta Mol Basis Dis2024https://conductscience.org/library/papers/38909847PubMed
1237104008MicroRNAs in Age-Related Proteostasis and Stress Responses.Noncoding RNA2023https://conductscience.org/library/papers/37104008PubMed
1328510041The Keap1-Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases.Biophys Rev2017https://conductscience.org/library/papers/28510041PubMed
1434679762Anti-Oxidative, Anti-Inflammatory and Anti-Apoptotic Effects of Flavonols: Targeting Nrf2, NF-κB and p53 Pathways in Neurodegeneration.Antioxidants (Basel)2021https://conductscience.org/library/papers/34679762PubMed
1527165229Evaluation of MiR-34 Family and DNA Methyltransferases 1, 3A, 3B Gene Expression Levels in Hepatocellular Carcinoma Following Treatment with Dendrosomal Nanocurcumin.Asian Pac J Cancer Prev2016https://conductscience.org/library/papers/27165229PubMed
1622198267Activation of the cAMP cascade in human fibroblast cultures rescues the activity of oxidatively damaged complex I.Free Radic Biol Med2012https://conductscience.org/library/papers/22198267PubMed
1728823106Mitochondrial outer membrane permeabilization: a focus on the role of mitochondrial membrane structural organization.Biophys Rev2017https://conductscience.org/library/papers/28823106PubMed
1820041405Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma.Hepatology2010https://conductscience.org/library/papers/20041405PubMed
1922113163Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy.Nat Rev Cancer2011https://conductscience.org/library/papers/22113163PubMed
209171922Role of the mitochondrial permeability transition pore in apoptosis.Biosci Rep1997https://conductscience.org/library/papers/9171922PubMed

See all 38 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn Papers
41427720Uncovering Hyperhomocysteinemia: Global Risk Patterns and Molecular Disruption in Brain and Vascular Health.J Neurochem2025https://conductscience.org/library/papers/41427720

Source PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
MIR34A407040PubTator's text mininghttps://conductscience.org/library/genes/407040NCBI Gene
NFE2L24780PubTator's text mininghttps://conductscience.org/library/genes/4780NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39733379

GET https://conductscience.org/api/papers/v1/39733379/references?page=2